Fatty acid receptor agonists Pancreatic beta cells and intestinal L cells express several types of G protein-coupled receptors for fatty acids that potentiate the secretion of insulin and GLP-1 [24]
2024;103(26):e38668
J., Strasser, A
Diabetic ketoacidosis (DKA) While considered lower-risk than with SGLT2 inhibitors, DKA can still occur in people with type 1 diabetes taking tirzepatide, particularly if the insulin dose is reduced too aggressively or if the person becomes unwell (e.g
GLP-1 Weight Loss Injections Recovery and Results GLP-1 shots require no downtime or recovery, but you may experience side effects like loss of appetite, nausea, vomiting, and diarrhea
Open access funding provided by Royal Library, Copenhagen University Library Ethics declarations Competing interests PR received grants from AstraZeneca, Bayer, Novo Nordisk A/S, as well as consulting fees from AstraZeneca, Astellas, Bayer, Boehringer Ingelheim, Gilead, Merck, Mundipharma, Novo Nordisk A/S and Sanofi
